The page is the record's research on the issuer — no analyst, no rating, no view. # UroGen Pharma Ltd. (NASDAQ: URGN) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is UroGen Pharma Ltd., listed on NASDAQ under ticker URGN, ISIN USM960881052. The LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-L3 exists. The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is Israel. The listing status is listed, not halted. ## The disclosure read The record holds 63 filings across 35 filing days in the window 2025-11-08 to 2026-11-08. Of these, 28 are directors' dealings, 21 are regulatory filings, 8 are results, 3 are corporate news, 2 are AGM/EGM filings, and 1 is a director change. The median gap between filing days is 6.5 days. The latest filing is dated 2026-11-04, is of type regulatory filing, and falls 4 days before the record date. On NASDAQ the median gap is 6.0 days across 4359 issuers, the median filing count is 52, and the median latency is 5.0 days. In sector 2834 Pharmaceutical Preparations the median gap is 6.0 days across 526 issuers, the median filing count is 63.0, and the median latency is 4.0 days. ## Auditor The auditor of record is PricewaterhouseCoopers LLP, located in Florham Park, New Jersey. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer is sealed for the years 2021, 2022, 2023, 2024, 2025, and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001668243.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/URGN (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1668243/000143774926006234/urgn20251231_10k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/URGN (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/URGN · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp